Takuma Narita

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 14, 2026
Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.

|Aug 15, 2026
Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

|May 16, 2022
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota

|Apr 01, 2022
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama

|Sep 22, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama

Pageof 1

Frequent Collaborators

6 joint publications

Shingo Hatakeyama

4 joint publications

Hayato Yamamoto

3 joint publications

Shintaro Narita

3 joint publications

Naoki Fujita